Process View
The lysis or structural demise of the corpus luteum. During normal luteolysis, two closely related events occur. First, there is loss of the capacity to synthesize and secrete progesterone (functional luteolysis) followed by loss of the cells that comprise the corpus luteum (structural luteolysis). Preventing luteolysis is crucial to maintain pregnancy.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "luteolysis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 1.000 | ||
| CPE | carboxypeptidase E | 0.999 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.985 | ||
| RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 0.939 | ||
| RAI1 | retinoic acid induced 1 | 0.898 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.812 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.724 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.568 | ||
| HNRNPL | heterogeneous nuclear ribonucleoprotein L | 0.553 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.407 | ||
| BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | 0.339 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.242 | ||
| VEGFC | vascular endothelial growth factor C | 0.231 | ||
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.227 | ||
| KCNRG | potassium channel regulator | 0.199 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.164 | ||
| MFAP4 | microfibrillar-associated protein 4 | 0.145 | ||
| PTN | pleiotrophin | 0.136 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.123 | ||
| RGS4 | regulator of G-protein signaling 4 | 0.122 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.120 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.118 | ||
| FAP | fibroblast activation protein, alpha | 0.099 | ||
| CHRD | chordin | 0.083 | ||
| GIGYF1 | GRB10 interacting GYF protein 1 | 0.081 | ||
| SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A | 0.078 | ||
| FLRT2 | fibronectin leucine rich transmembrane protein 2 | 0.076 | ||
| RXRA | retinoid X receptor, alpha | 0.076 | ||
| PCDH12 | protocadherin 12 | 0.074 | ||
| LTBP1 | latent transforming growth factor beta binding protein 1 | 0.074 | ||
| LAMA4 | laminin, alpha 4 | 0.073 | ||
| PPP1R1B | protein phosphatase 1, regulatory (inhibitor) subunit 1B | 0.069 | ||
| LTBP4 | latent transforming growth factor beta binding protein 4 | 0.069 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.069 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.067 | ||
| OMD | osteomodulin | 0.064 | ||
| PCDH17 | protocadherin 17 | 0.063 | ||
| OLFM2 | olfactomedin 2 | 0.061 | ||
| ECM1 | extracellular matrix protein 1 | 0.060 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.058 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.057 | ||
| MMP13 | matrix metallopeptidase 13 (collagenase 3) | 0.054 | Rat | |
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.050 | ||
| BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | 0.048 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.046 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.044 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.043 | ||
| CACNB1 | calcium channel, voltage-dependent, beta 1 subunit | 0.042 | ||
| SVEP1 | sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | 0.041 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.041 | ||
| PIP4K2B | phosphatidylinositol-5-phosphate 4-kinase, type II, beta | 0.040 | ||
| FMOD | fibromodulin | 0.040 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.040 | ||
| INHBA | inhibin, beta A | 0.039 | ||
| NOV | nephroblastoma overexpressed gene | 0.037 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.037 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.037 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.037 | ||
| ZNF331 | zinc finger protein 331 | 0.037 | ||
| SCG5 | secretogranin V (7B2 protein) | 0.035 | ||
| CHRDL1 | chordin-like 1 | 0.034 | ||
| PDPN | podoplanin | 0.034 | ||
| SLIT3 | slit homolog 3 (Drosophila) | 0.033 | ||
| DPT | dermatopontin | 0.033 | ||
| LENG8 | leukocyte receptor cluster (LRC) member 8 | 0.032 | ||
| PTHLH | parathyroid hormone-like hormone | 0.032 | ||
| JAM2 | junctional adhesion molecule 2 | 0.031 | ||
| FMO1 | flavin containing monooxygenase 1 | 0.029 | ||
| BNC2 | basonuclin 2 | 0.029 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.029 | ||
| GLI3 | GLI family zinc finger 3 | 0.029 | ||
| STEAP1 | six transmembrane epithelial antigen of the prostate 1 | 0.027 | ||
| ROBO1 | roundabout, axon guidance receptor, homolog 1 (Drosophila) | 0.027 | Human | |
| WNT2 | wingless-type MMTV integration site family member 2 | 0.027 | ||
| EPHA3 | EPH receptor A3 | 0.027 | ||
| STMN2 | stathmin-like 2 | 0.026 | ||
| OLFML1 | olfactomedin-like 1 | 0.025 | ||
| BCHE | butyrylcholinesterase | 0.025 | ||
| FRZB | frizzled-related protein | 0.025 | ||
| ZG16B | zymogen granule protein 16 homolog B (rat) | 0.025 | ||
| SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | 0.024 | ||
| KIAA0913 | KIAA0913 | 0.024 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.024 | ||
| ESM1 | endothelial cell-specific molecule 1 | 0.024 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.023 | ||
| NAV3 | neuron navigator 3 | 0.023 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.022 | ||
| NTM | neurotrimin | 0.022 | ||
| SEMA3A | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A | 0.022 | ||
| F10 | coagulation factor X | 0.022 | ||
| TCF21 | transcription factor 21 | 0.022 | ||
| RAD54L2 | RAD54-like 2 (S. cerevisiae) | 0.022 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.022 | ||
| SELE | selectin E | 0.022 | ||
| ZNF205 | zinc finger protein 205 | 0.022 | ||
| MEGF6 | multiple EGF-like-domains 6 | 0.021 | ||
| THBS4 | thrombospondin 4 | 0.021 | ||
| LDB2 | LIM domain binding 2 | 0.021 | ||
| CNTNAP1 | contactin associated protein 1 | 0.021 | ||
| COL13A1 | collagen, type XIII, alpha 1 | 0.020 | ||
| PRRX1 | paired related homeobox 1 | 0.020 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.020 | ||
| TNXB | tenascin XB | 0.020 | ||
| KCNC4 | potassium voltage-gated channel, Shaw-related subfamily, member 4 | 0.019 | ||
| SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.019 | ||
| FBLN1 | fibulin 1 | 0.019 | ||
| LOX | lysyl oxidase | 0.019 | ||
| FBXL7 | F-box and leucine-rich repeat protein 7 | 0.018 | ||
| MYCT1 | myc target 1 | 0.018 | ||
| IL13RA2 | interleukin 13 receptor, alpha 2 | 0.018 | ||
| ITGA8 | integrin, alpha 8 | 0.018 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.018 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.018 | ||
| VIP | vasoactive intestinal peptide | 0.018 | ||
| PRRX2 | paired related homeobox 2 | 0.017 | ||
| WNT5A | wingless-type MMTV integration site family, member 5A | 0.017 | ||
| PGF | placental growth factor | 0.017 | ||
| MEIS2 | Meis homeobox 2 | 0.017 | ||
| KIAA1462 | KIAA1462 | 0.017 | ||
| TREM2 | triggering receptor expressed on myeloid cells 2 | 0.017 | ||
| OGN | osteoglycin | 0.017 | ||
| CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.017 | ||
| SMCR7 | Smith-Magenis syndrome chromosome region, candidate 7 | 0.017 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.017 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.017 | ||
| LRRN3 | leucine rich repeat neuronal 3 | 0.017 | ||
| CDKAL1 | CDK5 regulatory subunit associated protein 1-like 1 | 0.016 | ||
| COL21A1 | collagen, type XXI, alpha 1 | 0.016 | ||
| ERP27 | endoplasmic reticulum protein 27 | 0.016 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.016 | ||
| LAMA2 | laminin, alpha 2 | 0.016 | ||
| STC1 | stanniocalcin 1 | 0.016 | ||
| GKAP1 | G kinase anchoring protein 1 | 0.016 | ||
| PLXDC1 | plexin domain containing 1 | 0.016 | ||
| PALM | paralemmin | 0.016 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.016 | ||
| HOXD10 | homeobox D10 | 0.016 | ||
| PTPRG | protein tyrosine phosphatase, receptor type, G | 0.015 | ||
| GPC3 | glypican 3 | 0.015 | ||
| SCG2 | secretogranin II | 0.015 | ||
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.015 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.015 | ||
| PGM5 | phosphoglucomutase 5 | 0.015 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.015 | ||
| CCDC21 | coiled-coil domain containing 21 | 0.015 | ||
| SPON1 | spondin 1, extracellular matrix protein | 0.015 | ||
| LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0.015 | ||
| S100A2 | S100 calcium binding protein A2 | 0.015 | ||
| ADAM33 | ADAM metallopeptidase domain 33 | 0.015 | ||
| GAP43 | growth associated protein 43 | 0.014 | ||
| NFIX | nuclear factor I/X (CCAAT-binding transcription factor) | 0.014 | ||
| MSC | musculin | 0.014 | ||
| LPPR4 | lipid phosphate phosphatase-related protein type 4 | 0.014 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.014 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.014 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.014 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.014 | ||
| CORIN | corin, serine peptidase | 0.014 | ||
| TRPC6 | transient receptor potential cation channel, subfamily C, member 6 | 0.014 | ||
| EFCAB4B | EF-hand calcium binding domain 4B | 0.014 | ||
| ITGBL1 | integrin, beta-like 1 (with EGF-like repeat domains) | 0.014 | ||
| EMCN | endomucin | 0.014 | ||
| SPAG8 | sperm associated antigen 8 | 0.014 | ||
| C20orf103 | chromosome 20 open reading frame 103 | 0.013 | ||
| C4orf31 | chromosome 4 open reading frame 31 | 0.013 | ||
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.013 | ||
| CLSTN2 | calsyntenin 2 | 0.013 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.013 | ||
| JAG2 | jagged 2 | 0.013 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.013 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.013 | ||
| ASPN | asporin | 0.013 | ||
| GLT8D2 | glycosyltransferase 8 domain containing 2 | 0.013 | ||
| CNIH3 | cornichon homolog 3 (Drosophila) | 0.013 | ||
| PDGFD | platelet derived growth factor D | 0.013 | ||
| DOC2B | double C2-like domains, beta | 0.013 | ||
| PTPRD | protein tyrosine phosphatase, receptor type, D | 0.013 | ||
| USF1 | upstream transcription factor 1 | 0.013 | ||
| GTF2I | general transcription factor IIi | 0.013 | ||
| SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.013 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.013 | ||
| SEMA3G | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G | 0.013 | ||
| STAC | SH3 and cysteine rich domain | 0.013 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.013 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.012 | ||
| COL11A1 | collagen, type XI, alpha 1 | 0.012 | ||
| ZFHX4 | zinc finger homeobox 4 | 0.012 | ||
| C1QTNF1 | C1q and tumor necrosis factor related protein 1 | 0.012 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.012 | ||
| TRO | trophinin | 0.012 | ||
| CD248 | CD248 molecule, endosialin | 0.012 | ||
| PRR3 | proline rich 3 | 0.012 | ||
| RGS5 | regulator of G-protein signaling 5 | 0.012 | ||
| SLC16A7 | solute carrier family 16, member 7 (monocarboxylic acid transporter 2) | 0.012 | ||
| DARC | Duffy blood group, chemokine receptor | 0.012 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.012 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.012 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.012 | ||
| S100A3 | S100 calcium binding protein A3 | 0.012 | ||
| PTX3 | pentraxin 3, long | 0.012 | ||
| PAMR1 | peptidase domain containing associated with muscle regeneration 1 | 0.012 | ||
| PLAT | plasminogen activator, tissue | 0.012 | ||
| ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | 0.012 | ||
| PLN | phospholamban | 0.012 | ||
| LIMS2 | LIM and senescent cell antigen-like domains 2 | 0.012 | ||
| PTGFR | prostaglandin F receptor (FP) | 0.012 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.012 | ||
| FGF3 | fibroblast growth factor 3 | 0.012 | ||
| PCDH18 | protocadherin 18 | 0.012 | ||
| OPCML | opioid binding protein/cell adhesion molecule-like | 0.012 | ||
| RERGL | RERG/RAS-like | 0.012 | ||
| DGKI | diacylglycerol kinase, iota | 0.012 | ||
| ITPRIPL1 | inositol 1,4,5-trisphosphate receptor interacting protein-like 1 | 0.012 | ||
| MFAP5 | microfibrillar associated protein 5 | 0.011 | ||
| CST1 | cystatin SN | 0.011 | ||
| UTP20 | UTP20, small subunit (SSU) processome component, homolog (yeast) | 0.011 | ||
| SSTR2 | somatostatin receptor 2 | 0.011 | ||
| TCF4 | transcription factor 4 | 0.011 | ||
| MEOX1 | mesenchyme homeobox 1 | 0.011 | ||
| STEAP4 | STEAP family member 4 | 0.011 | ||
| FBN2 | fibrillin 2 | 0.011 | ||
| GUCY1A2 | guanylate cyclase 1, soluble, alpha 2 | 0.011 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.011 | Rat | |
| COLEC12 | collectin sub-family member 12 | 0.011 | ||
| PDE1A | phosphodiesterase 1A, calmodulin-dependent | 0.011 | ||
| RBP4 | retinol binding protein 4, plasma | 0.011 | ||
| ISLR | immunoglobulin superfamily containing leucine-rich repeat | 0.011 | ||
| TMEM158 | transmembrane protein 158 (gene/pseudogene) | 0.011 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.011 | ||
| MOCS3 | molybdenum cofactor synthesis 3 | 0.011 | ||
| SGCD | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) | 0.011 | ||
| WNT3 | wingless-type MMTV integration site family, member 3 | 0.011 | ||
| ADAMTS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | 0.011 | ||
| CCDC3 | coiled-coil domain containing 3 | 0.011 | ||
| PLA2G5 | phospholipase A2, group V | 0.011 | ||
| SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) | 0.011 | ||
| NOVA2 | neuro-oncological ventral antigen 2 | 0.011 | ||
| TMSB4Y | thymosin beta 4, Y-linked | 0.011 | ||
| CTSG | cathepsin G | 0.011 | ||
| GNB5 | guanine nucleotide binding protein (G protein), beta 5 | 0.011 | ||
| BAIAP2 | BAI1-associated protein 2 | 0.011 | ||
| MARCO | macrophage receptor with collagenous structure | 0.011 | ||
| RASSF9 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 | 0.011 | ||
| OLFML3 | olfactomedin-like 3 | 0.011 | ||
| PLVAP | plasmalemma vesicle associated protein | 0.011 | ||
| BDKRB1 | bradykinin receptor B1 | 0.011 | ||
| PDE3A | phosphodiesterase 3A, cGMP-inhibited | 0.011 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.011 | ||
| BOC | Boc homolog (mouse) | 0.011 | ||
| CALCRL | calcitonin receptor-like | 0.010 | ||
| GPX7 | glutathione peroxidase 7 | 0.010 | ||
| WNT2B | wingless-type MMTV integration site family, member 2B | 0.010 | ||
| ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | 0.010 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.010 | ||
| C7 | complement component 7 | 0.010 | ||
| IL1RL1 | interleukin 1 receptor-like 1 | 0.010 | ||
| CHRNA5 | cholinergic receptor, nicotinic, alpha 5 | 0.010 | ||
| MED25 | mediator complex subunit 25 | 0.010 | ||
| ZNF385D | zinc finger protein 385D | 0.010 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.010 | ||
| NACAD | NAC alpha domain containing | 0.010 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.010 | ||
| GSTT1 | glutathione S-transferase theta 1 | 0.010 |